Counter-Chemical, Biological, Radiological, Nuclear and Explosive protection
5 April 2019
To ensure Australian Defence Force personnel have the best possible protection, Defence has signed a $26 million five-year contract with the South Australian-based company, Babcock Pty Ltd, as prime vendor for Counter-Chemical, Biological, Radiological, Nuclear and Explosive (C-CBRNE) support.
Babcock has been selected through a worldwide open tender process based on their ability to provide expertise and industry best practice to deliver the solution to Defence requirements.
The establishment of Babcock as prime vendor is a key reform initiative to realise savings and efficiencies in the management of the existing commercially available C-CBRNE capability, and in the acquisition of new C-CBRNE capabilities, including for Project Land 3025 Phase 2 Deployable Special Operations Engineer capability.
The C-CBRNE capability provides leading-edge technologies to prevent and defeat chemical, biological, radiological, nuclear and explosive threats used against Australia’s national interests.
Under the contract Babcock has undertaken to create up to 11 jobs in Australia for up to 15 years.